Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 3581-3590 Newer>

The Motley Fool April 2, 2007 Brian Lawler	Pain Therapeutics Pares Shares The small drugmaker announces a share buyback.
Managed Care March 2007 Tom Reinke	NCQA Shifts Focus On Physician Performance NCQA's 2007 HEDIS physician performance manual puts greater emphasis on cost of care. Many organizations, including some health plans, use these specifications to evaluate physician performance.
Managed Care March 2007	Use of Generics On the Rise Recent data indicate that generic medication accounts for nearly 60% of the drugs dispensed to people in Medicare Prescription Drug Plans and Medicare Advantage plans.
Managed Care March 2007 Martin Sipkoff	Plans, PBMs, Employers Prod Docs To E-Prescribe Widespread adoption of electronic prescribing is inevitable, yet physicians still resist. Various coalitions and initiatives are trying to make adoption easier.
Chemistry World April 2007 Richard Barker	Comment: Pricing Pills An Office of Fair Trading report claims The UK's National Health Service is paying over the odds for its drugs, but this is not so. Medicine prices are 21% lower in real terms than ten years ago.
The Motley Fool March 30, 2007 Ralph Casale	Another Genetic Sequencer Gobbled Up Roche buys out second-generation sequencer 454 Life Sciences. Investors, take note.
Chemistry World March 29, 2007	Sanofi-Aventis and Oxford BioMedica Enter Licensing Agreement UK biotech firm Oxford BioMedica has licensed its leading cancer drug, TroVax, to France's Sanofi-Aventis.
The Motley Fool March 29, 2007 Michael P. Cecil	Stents on Trial New study results could affect stent sales -- at least in the short term.
InternetNews March 28, 2007 Michael Hickins	An Accenture on Health IT Accenture is pulling together different technologies to create an end-to-end electronic health network.
The Motley Fool March 28, 2007 Brian Lawler	Nuvelo Gets Fast One of Nuvelo's compounds gets fast track designation. Investors, take note.
<Older 3581-3590 Newer> Return to current articles.